Genzyme and Isis announce FDA approval of KYNAMRO™ injection for the treatment of HoFH
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
List view / Grid view
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
29 January 2013 | By Boehringer Ingelheim
Olodaterol may provide a new treatment option in patients with COPD...
28 January 2013 | By Burson-Marsteller
Norgine Pharmaceuticals Limited and Alfa Wassermann are pleased to announce the launch of TARGAXAN® 550 in the UK...
28 January 2013 | By Sanofi
Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.
28 January 2013 | By Sanofi
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions...
28 January 2013 | By GlaxoSmithKline
GSK and Biological E. announced an agreement to form a 50/50 joint venture...
26 January 2013 | By Amgen
Results from Pegfilgrastim and Anti-VEGF Evaluation Study...
25 January 2013 | By Pfizer
Prevnar 13 is the first and only pneumococcal conjugate vaccine approved for this age group...
25 January 2013 | By Merck
Merck announced that the U.S. FDA has approved OXYTROL FOR WOMEN, the first and only over-the-counter treatment for overactive bladder in women...
25 January 2013 | By Amgen
"Amgen endorses state policies that would put patients first..."
24 January 2013 | By The Words Workshop Ltd
On 1 January 2013 Heinrich Meintrup took over his new role as Group Managing Director...
24 January 2013 | By Cision
“Anders Hamsten will be an excellent president. It is also very gratifying that he has solid support from within the organisation”
24 January 2013 | By Roche
Roche announced that the US FDA approved a new use of Avastin...
24 January 2013 | By Pfizer
New data add to evidence supporting PRISTIQ as a treatment option for MDD...
24 January 2013 | By GlaxoSmithKline
GlaxoSmithKline announced the appointment of Hans Wijers to its Board as a Non-Executive Director, effective 1st April 2013...